About this trial
To evaluate the therapeutic efficacy and metabolic impact of a low energy diet (LED) in people with familial partial lipodystrophy and diabetes. Participants will be provided with a LED (total diet replacement) for 12 weeks, before the introduction of a stepped food transition. Metabolic effects will continue to be assessed for 1 year. In order to better understand why this intervention changes insulin sensitivity, we will also collect adipose and muscle tissue samples at baseline and 12 weeks into the intervention in participants willing to have these procedures performed. These samples will be used for histological, metabolite, gene expression and protein expression analyses.
Eligibility criteria
Qualifiers
Familial Partial Lipodystrophy
Age >= 18 yrs
T2DM
Willingness to check daily blood sugars
Disqualifiers
Pregnancy
Untreated thyroid dysfunction (patients who have been euthyroid on medication for at least 3 months can be included)
Use of medication adversely that affects diabetes control (e.g. steroids/ immunosuppressants/ certain antipsychotics)
Incapacity to give informed consent
Trial design
Treatments tested in this trial
- Total Dietary Replacement
Treatment groups
Locations
1Sponsors and collaborators
Cambridge University Hospitals NHS Foundation Trust
Lead sponsor